06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.03
+1.49%Aug 26, 2026, 10:27 UTC
Pharmaceutical company Yaojie Ankang (02617.HK) reported interim results for the six months ended June 2026, with revenue of RMB 35.46 million and a narrowed net loss of RMB 95.47 million, compared with a loss of RMB 123 million in the same period last year.
Source:Aug 6, 2026, 23:32 UTC
Transcenta Holding announced the sale of its CDMO assets to WuXi Biologics for RMB 190 million, excluding intellectual property related to its candidate drug pipeline and core biomanufacturing platform.
Source:Jul 28, 2026, 00:08 UTC
CStone Pharmaceuticals successfully completed the renewal and extension of approximately RMB 85 million in bank loans.
Source: